Allianz SE Buys 5,182 Shares of Aflac Incorporated (NYSE:AFL)

Allianz SE raised its stake in Aflac Incorporated (NYSE:AFL - Free Report) by 59.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 13,902 shares of the financial services provider's stock after buying an additional 5,182 shares during the period. Allianz SE's holdings in Aflac were worth $1,546,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Golden State Wealth Management LLC grew its holdings in Aflac by 121.9% during the 1st quarter. Golden State Wealth Management LLC now owns 304 shares of the financial services provider's stock worth $34,000 after acquiring an additional 167 shares during the period. Garde Capital Inc. bought a new stake in shares of Aflac during the 1st quarter valued at about $36,000. Meeder Asset Management Inc. grew its stake in Aflac by 90.8% during the first quarter. Meeder Asset Management Inc. now owns 330 shares of the financial services provider's stock worth $37,000 after purchasing an additional 157 shares during the period. Capital A Wealth Management LLC bought a new stake in shares of Aflac in the 4th quarter valued at $38,000. Finally, NBC Securities Inc. bought a new stake in Aflac in the first quarter valued at $44,000. Institutional investors and hedge funds own 67.44% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on AFL shares. Morgan Stanley boosted their price objective on Aflac from $100.00 to $105.00 and gave the company an "equal weight" rating in a report on Monday, May 19th. JPMorgan Chase & Co. increased their price objective on shares of Aflac from $96.00 to $100.00 and gave the company a "neutral" rating in a research note on Tuesday, July 8th. Wall Street Zen cut Aflac from a "hold" rating to a "sell" rating in a research note on Monday, May 5th. Wells Fargo & Company upped their price objective on Aflac from $103.00 to $105.00 and gave the company an "equal weight" rating in a research note on Thursday, July 10th. Finally, Raymond James Financial lowered their target price on Aflac from $115.00 to $110.00 and set an "outperform" rating on the stock in a research note on Thursday, May 29th. Three analysts have rated the stock with a sell rating, eight have issued a hold rating and three have given a buy rating to the stock. According to data from MarketBeat.com, Aflac currently has a consensus rating of "Hold" and a consensus target price of $108.15.

Insider Activity

In other Aflac news, Director Masatoshi Koide sold 37,000 shares of the stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $105.59, for a total value of $3,906,830.00. Following the sale, the director directly owned 70,992 shares in the company, valued at $7,496,045.28. This represents a 34.26% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Joseph L. Moskowitz sold 1,000 shares of the firm's stock in a transaction on Thursday, May 8th. The shares were sold at an average price of $106.79, for a total transaction of $106,790.00. Following the completion of the transaction, the director directly owned 26,096 shares of the company's stock, valued at approximately $2,786,791.84. The trade was a 3.69% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 40,750 shares of company stock worth $4,304,295 over the last ninety days. Company insiders own 0.80% of the company's stock.

Aflac Stock Performance

NYSE:AFL opened at $98.10 on Monday. The business's fifty day moving average is $102.58 and its 200 day moving average is $105.05. The firm has a market cap of $53.04 billion, a price-to-earnings ratio of 15.33, a PEG ratio of 3.03 and a beta of 0.83. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.09 and a current ratio of 0.09. Aflac Incorporated has a 52-week low of $95.97 and a 52-week high of $115.50.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.